Onxeo Announces Evolution in the Board of Directors
October 06, 2015 13:12 ET
|
Onxeo SA
· Mr. Patrick Langlois is planning to step down from the chairmanship in early
2016 for personal reasons
· Mr. Joseph Zakrzewski is joining the Board and is expected to be appointed
Non-Executive...
Onxeo offentliggør ændring i bestyrelsen
October 06, 2015 13:12 ET
|
Onxeo SA
· Patrick Langlois planlægger at fratræde som bestyrelsesformand i starten af
2016 af personlige årsager
· Joseph Zakrzewski indtræder i bestyrelsen og ventes at blive udnævnt til
ekstern formand...
Onxeo announces positive DSMB recommendation for continuation of Livatag® ReLive study in HCC
October 05, 2015 12:54 ET
|
Onxeo SA
PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ Copenhagen:
ONXEO), an innovative...
Onxeo offentliggør positiv anbefaling fra DSMB om at fortsætte ReLive-studiet med Livatag® mod leverkræft
October 05, 2015 12:54 ET
|
Onxeo SA
PARIS & KØBENHAVN, Danmark--(BUSINESS WIRE (http://www.businesswire.com/))--
Fondsbørsmeddelelse:
Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ Copenhagen:
ONXEO), et innovativt...
Onxeo S.A.: Offentliggørelse af nyt aktionærbrev
September 30, 2015 12:13 ET
|
Onxeo SA
PARIS & KØBENHAVN, Danmark--(BUSINESS WIRE (http://www.businesswire.com/))--
Fondsbørsmeddelelse:
Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO), et innovativt selskab med speciale
i udvikling af...
Onxeo S.A.: Publication of a New Letter to Shareholders
September 30, 2015 12:10 ET
|
Onxeo SA
PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO), an innovative company specializing
in the development of...
Décision dans le litige opposant Onxeo aux sociétés Eurofins et ABL.
September 22, 2015 15:04 ET
|
Onxeo SA
· Reconnaissance de la créance d’Onxeo au titre de l’Option prévue au contrat
· Compensation de cette créance par des dommages et intérets d’un montant
similaire au bénéfice d’Eurofins
· In...
Onxeo S.A.: Decision in the litigation against Eurofins and ABL companies
September 22, 2015 15:04 ET
|
Onxeo SA
· Recognition of an Eurofins debt to Onxeo as the price of the Option under
the contract
· Set-off of this debt against damages in the same amount awarded to Eurofins
· In fine, no payment is...
Corporate Governance prize awarded by AGEFI: Onxeo receives “Silver Governance” for the second consecutive year
September 17, 2015 02:31 ET
|
Onxeo SA
PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)-- Regulatory News:
Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ Copenhagen:
ONXEO), an innovative biopharmaceutical company...
Onxeo Files Application for Key Livatag® Patent
September 15, 2015 12:04 ET
|
Onxeo SA
Potential expansion of Livatag IP estate to extend commercial exclusivity
through 2036
PARIS & COPENHAGEN--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
Onxeo S.A. (Euronext...